Monoclonal antibodies in Epstein-Barr virus-related nasopharyngeal carcinoma: prognostic and therapeutic implications.
Levine
P H
PH
Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD.
Pearson
G R
GR
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000627:therapeutic use; D000956:Antigens, Viral / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis* / Q000628:therapy; D011379:Prognosis
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D000956:Antigens, Viral